ArticleBMC medical imaging2026
Combining computed tomography radiomics and clinical features to predict lymph node metastasis in patients with lung cancer.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAccurate preoperative assessment of lymph node metastasis (LNM) is crucial for treatment planning and prognostic stratification in patients with lung cancer. This study aimed to develop and validate a predictive model for LNM using radiomic features derived from non-contrast computed tomography (CT) combined with clinical characteristics.
methodsA total of 403 patients with pathologically confirmed lung cancer were retrospectively enrolled and randomly divided into a training set (n = 282) and an internal test set (n = 121). In addition,30 lung cancer patients from other hospital were collected as an external test set. Clinical variables were collected, and radiomic features were extracted from non-contrast chest CT images using the Radiomics module of 3D Slicer. Feature selection was performed using least absolute shrinkage and selection operator (LASSO) regression. Multiple machine-learning models were constructed based on radiomic features and clinical features. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), and clinical utility was evaluated by decision curve analysis (DCA). Shapley additive explanations (SHAP) were applied to enhance model interpretability.
resultsLymph node metastasis was observed in 35.5% (143/403) of patients. 2 clinical features and 16 radiomic features most strongly associated with LNM were identified. Among the nine constructed models, the combined clinical-radiomic support vector machine (SVM) model demonstrated the best predictive performance, with AUCs of 0.927 in the training set, 0.852 in the internal test set, and 0.812 in the external test set. Decision curve analysis indicated that the combined model provided a favorable net clinical benefit across a wide range of threshold probabilities.
conclusionThe proposed clinical-radiomic model based on non-contrast CT achieved good performance in predicting lymph node metastasis in patients with lung cancer and may serve as a noninvasive tool to assist individualized clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.